Assessment of mesorectal fascia status in MRI compared with circumferential resection margin after total mesorectal excision and predictors of involved margins.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
10 2022
Historique:
received: 10 03 2022
revised: 19 05 2022
accepted: 05 06 2022
pubmed: 16 8 2022
medline: 28 9 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

Circumferential resection margin is an important prognosticator for total mesorectal excision outcome. We investigated the status of mesorectal fascia on magnetic resonance imaging compared with circumferential resection margin on pathology and factors associated with status change. This was a retrospective analysis of a prospective database of rectal cancer patients who underwent surgery. Mesorectal fascia status on magnetic resonance imaging done before neoadjuvant therapy and circumferential resection margin status on pathology were compared. The study outcomes were factors associated with a margin status conversion between magnetic resonance imaging and pathology, and predictors of involved circumferential resection margin. In total, 244 patients (average follow-up of 25.4 months) were included. Eighty-one (33.2%) patients had potentially involved mesorectal fascia in magnetic resonance imaging and 12 (4.9%) had involved circumferential resection margin in pathology. A total of 2.8% of patients had a conversion of clear mesorectal fascia in magnetic resonance imaging to involved circumferential resection margin. Abdominoperineal resection was significantly associated with this status change (odds ratio: 25, 95% confidence interval: 2.4-255.8, P = .007). In total, 7.4% of patients with potentially involved mesorectal fascia had persistently involved circumferential resection margin. Lack of total neoadjuvant therapy was associated with higher, yet statistically insignificant, odds of persistently involved circumferential resection margin (odds ratio: 12, 95% confidence interval: 0.65-220.8, P = .09). The significant independent predictors of involved circumferential resection margin were body mass index (odds ratio: 1.2, P = .016) and abdominoperineal resection (odds ratio: 4.22, P = .04). Change of clear mesorectal fascia in magnetic resonance imaging to an involved circumferential resection margin in pathology was recorded in 2.8% of patients; abdominoperineal resection might be associated with this change. Approximately 7% of patients had persistent involvement of circumferential resection margin as determined by pathology. Omission of total neoadjuvant therapy might be associated with persistent margin involvement.

Sections du résumé

BACKGROUND
Circumferential resection margin is an important prognosticator for total mesorectal excision outcome. We investigated the status of mesorectal fascia on magnetic resonance imaging compared with circumferential resection margin on pathology and factors associated with status change.
METHODS
This was a retrospective analysis of a prospective database of rectal cancer patients who underwent surgery. Mesorectal fascia status on magnetic resonance imaging done before neoadjuvant therapy and circumferential resection margin status on pathology were compared. The study outcomes were factors associated with a margin status conversion between magnetic resonance imaging and pathology, and predictors of involved circumferential resection margin.
RESULTS
In total, 244 patients (average follow-up of 25.4 months) were included. Eighty-one (33.2%) patients had potentially involved mesorectal fascia in magnetic resonance imaging and 12 (4.9%) had involved circumferential resection margin in pathology. A total of 2.8% of patients had a conversion of clear mesorectal fascia in magnetic resonance imaging to involved circumferential resection margin. Abdominoperineal resection was significantly associated with this status change (odds ratio: 25, 95% confidence interval: 2.4-255.8, P = .007). In total, 7.4% of patients with potentially involved mesorectal fascia had persistently involved circumferential resection margin. Lack of total neoadjuvant therapy was associated with higher, yet statistically insignificant, odds of persistently involved circumferential resection margin (odds ratio: 12, 95% confidence interval: 0.65-220.8, P = .09). The significant independent predictors of involved circumferential resection margin were body mass index (odds ratio: 1.2, P = .016) and abdominoperineal resection (odds ratio: 4.22, P = .04).
CONCLUSION
Change of clear mesorectal fascia in magnetic resonance imaging to an involved circumferential resection margin in pathology was recorded in 2.8% of patients; abdominoperineal resection might be associated with this change. Approximately 7% of patients had persistent involvement of circumferential resection margin as determined by pathology. Omission of total neoadjuvant therapy might be associated with persistent margin involvement.

Identifiants

pubmed: 35970606
pii: S0039-6060(22)00426-3
doi: 10.1016/j.surg.2022.06.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1085-1092

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Sameh Hany Emile (SH)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL; Colorectal Surgery Unit, General Surgery Department, Mansoura University Hospitals, Mansoura, Egypt. Electronic address: https://twitter.com/dr_samehhany81.

Nir Horesh (N)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/nirhoresh.

Michael R Freund (MR)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/mikifreund.

Albert Parlade (A)

Department of Imaging, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/ajparlade.

Arun Nagarajan (A)

Department of Hematology and Medical Oncology, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/ArunNagarajanMD.

Zoe Garoufalia (Z)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/ZGaroufalia.

Rachel Gefen (R)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL.

Emanuela Silva-Alvarenga (E)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/EmanuelaSilvaA1.

Giovanna Dasilva (G)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/dasilvg.

Steven D Wexner (SD)

Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL. Electronic address: wexners@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH